Laura Huang
About Laura Huang
Laura Huang (age 45) is an independent Class A director of Nuvve Holding Corp., appointed effective June 25, 2025. She is a Distinguished Professor of Management and Organizational Development at Northeastern University and previously held faculty positions at Harvard Business School and Wharton; her expertise spans organizational transformation, decision-making, risk management, M&A strategy, AI adoption, and global expansion, with prior industry roles at Standard Chartered Bank, IBM Global Services, and Johnson & Johnson . She was elected to a three-year term at the August 22, 2025 annual meeting, serving through the 2028 annual meeting unless earlier departure .
Past Roles
| Organization | Role/Function | Tenure | Committees/Impact |
|---|---|---|---|
| Northeastern University | Distinguished Professor; Associate Dean of Executive Education | Not disclosed | Academic leadership; research in decision-making and innovation |
| Harvard Business School | Faculty | Not disclosed | Teaching/research (strategy, judgment) |
| Wharton School, University of Pennsylvania | Faculty | Not disclosed | Teaching/research; M&A/innovation advising |
| Standard Chartered Bank | Roles in financial services | Not disclosed | Technology strategy; product initiatives |
| IBM Global Services | Roles in technology strategy | Not disclosed | Technology strategy; risk management |
| Johnson & Johnson | Roles in product development | Not disclosed | Product development; innovation |
External Roles
| Organization | Role | Nature | Tenure | Notes |
|---|---|---|---|---|
| Uber | Diversity Advisory Council member | Advisory board | Not disclosed | Advises on diversity strategy |
| Wharton Alumni Angels | Advisor/Board involvement | Advisory / supervisory | Not disclosed | Startup/innovation ecosystem |
| Women 2.0 | Advisor/Board involvement | Advisory / supervisory | Not disclosed | Women in tech initiatives |
Board Governance
- Board classification: Class A/B/C staggered terms; Huang is Class A (expiring 2025, re-elected in 2025) .
- Committee memberships: Compensation Committee member; Nominating & Corporate Governance Committee member (effective upon appointment) .
- Independence: Board determined Compensation and Nominating & Corporate Governance members are independent under Nasdaq rules; Huang serves on both committees as an independent director .
- Attendance: In FY2024, Board met 19 times; all directors met ≥75% attendance across Board and committees (note: Huang joined in 2025; FY2024 attendance disclosure covers prior directors) .
- Audit Committee oversight: Reviews related-party transactions; meets at least quarterly .
- Executive sessions: Independent directors meet in executive session regularly without management .
Fixed Compensation
| Component | Annual Amount (USD) | Notes |
|---|---|---|
| Director cash retainer | $40,000 | Non-employee director retainer |
| Committee chair – Audit | $20,000 | Incremental for chair |
| Committee chair – Compensation | $15,000 | Incremental for chair |
| Committee chair – Nominating & Governance | $10,000 | Incremental for chair |
| Committee member – Audit | $10,000 | Incremental for membership |
| Committee member – Compensation | $7,500 | Incremental for membership |
| Committee member – Nominating & Governance | $5,000 | Incremental for membership |
| Chairperson of the Board (additional) | $70,000 | Incremental; not applicable to Huang |
| Non-employee director annual cap | $400,000 | Total cash + grant-date value cap; exceptions allowed in extraordinary cases |
Huang, as a non-employee director and committee member (Compensation; Nominating & Governance), is eligible under this program; actual cash paid to her for 2025 is not separately disclosed and would be pro-rated from appointment date .
Performance Compensation
| Award Type | Grant Date | Quantity | Vesting / Terms | Fair Value | Notes |
|---|---|---|---|---|---|
| Common stock award (Form 4 “A”) | 2025-08-24 | 100,000 shares | Not disclosed in proxy; Form 4 reports award at $0 price | Not disclosed | Post-transaction ownership 100,000 shares (director) |
Performance metrics tied to director compensation: Not disclosed for director grants; Compensation Committee charter permits performance-based incentives for executives; plan allows performance goals generally but no director-specific metrics are provided .
Change-of-control and vesting provisions (plan-level):
- If change of control not authorized by Board: all outstanding awards immediately vest; performance goals deemed achieved at 100% .
- If asset sale or Board-approved change of control: Committee may accelerate vesting, cash-settle awards, or terminate performance periods and pay based on goal attainment .
Other Directorships & Interlocks
| Company | Exchange/Ticker | Role | Committees | Potential Interlocks/Conflicts |
|---|---|---|---|---|
| None disclosed | — | — | — | No public company directorships disclosed for Huang . |
Family relationships and related-party exposure:
- No familial relationships among directors/executives; Huang: none disclosed .
- No material related-party transactions for Huang (Item 404(a)) .
- Company policy requires Audit Committee review/approval of any related-party transactions; code of ethics addresses conflicts .
Expertise & Qualifications
- Degrees: Ph.D. (UC Irvine), MBA (INSEAD), dual BSE (Electrical and Biomedical Engineering, Duke) .
- Technical/functional expertise: Organizational transformation, strategic growth, risk management, decision-making, innovation; advisory work on M&A strategy and AI adoption .
- Committee experience: Audit, compensation, strategic oversight on advisory/supervisory boards .
Equity Ownership
| As-of Date | Shares Beneficially Owned | % of Outstanding Shares | Source |
|---|---|---|---|
| June 25, 2025 | — (0) | <1% | Director/beneficial ownership table; 10,613,022 shares outstanding |
| September 4, 2025 | 100,000 | ~0.49% (100,000 / 20,252,314) | Beneficial ownership table; 20,252,314 shares outstanding |
- Vested vs. unvested: Not disclosed.
- Options/derivatives: None disclosed for Huang .
- Pledging/hedging: Insider trading policy adopted; no pledging disclosed for Huang .
Insider Trades (Form 3/4)
| Filing Date | Transaction Date | Form | Type | Securities Transacted | Price | Post-Transaction Ownership | SEC Link |
|---|---|---|---|---|---|---|---|
| 2025-07-07 | 2025-05-20 | Form 3 | Initial statement | — | — | — | |
| 2025-08-26 | 2025-08-24 | Form 4 | A – Award/Grant | 100,000 shares (Common Stock) | $0.00 | 100,000 (director, direct) |
Governance Assessment
- Independence and committee roles: Strong indicator of governance quality; Huang serves on Compensation and Nominating & Governance committees deemed independent under Nasdaq rules .
- Shareholder support: Elected with 668,665 “For” vs. 104,868 “Withheld” votes; broker non-votes 3,898,895, indicating solid backing among votes cast .
- Ownership alignment: Received 100,000-share equity grant in Aug-2025; beneficial ownership increased from 0 to 100,000 shares by Sep-2025 (~0.49% of outstanding at that time), improving alignment but still modest in percentage terms .
- Related-party/conflicts: No Item 404(a) transactions or family ties disclosed; Audit Committee pre-approves related-party transactions under policy .
- Attendance and engagement: Board-level disclosure indicates robust meeting cadence (19 meetings in FY2024) and ≥75% attendance for directors; Huang joined in 2025—no specific attendance metrics disclosed for her yet .
RED FLAGS: None identified specific to Huang. No hedging/pledging disclosed, no related-party transactions, and independent committee membership. Monitoring point: clarity of vesting/performance conditions for director equity awards is not disclosed; track future proxies for director ownership guidelines and compliance .